March 24, 2025

Hong Kong – Visen Pharmaceutical HK$783.3 million IPO.

March 20, 2025

China – Linklaters Advises On Landmark Convertible Bond And Concurrent Share Repurchase.

March 19, 2025

US – Personae Non Gratae In The Loan Market: Trading Considerations For Disqualified Institutions.

March 19, 2025

US – SEC Issues No-Action Letter Clarifying Accredited Investor Verification Under Rule 506(C).

March 14, 2025

Germany – Baidu Offers Zero-Coupon Exchangeable Bonds.

March 14, 2025

Skadden Advises Meiji Yasuda Life Insurance Company On Its US$2.1 Billion Subordinated Notes Issuance.

March 13, 2025

Hong Kong – Skadden Advises Baidu, Inc. On Its US$2 Billion Offering Of Zero Coupon Exchangeable Bonds.

March 12, 2025

Baker Mckenzie Advises China Ruyi Holdings Limited On Its HKD3.875 Billion Shares Placement.

March 11, 2025

India – Pro-Rata And Pari-Passu Rights: Regulating The Differential Rights For AIF Investors.

- Vivaik Sharma - Cyril Amarchand Mangaldas, Cyril Amarchand Mangaldas

March 6, 2025

FTSE Russell Widens Access To Its UK Index Series.

March 6, 2025

Linklaters Advises Citi And Itau BBA On The Republic Of Paraguay’s International Bond Offering And Concurrent Tender Offer.

March 6, 2025

Oman – Linklaters Advises Asyad Shipping And Its Selling Shareholder On Its IPO On The Muscat Stock Exchange.